Mobile Technology for Blood Pressure Management

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-31

Study Completion Date

2021-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Technology-enabled Management Versus Usual Care for Blood Pressure

NCT05479461

Hypertension

RECRUITING NA

Remote Monitoring and Social Support for Hypertension Management

NCT03416283

Hypertension

COMPLETED NA

WIreless Monitoring and Financial Incentives for Uncontrolled HYpertension (WIFHY) Study

NCT03368417

Hypertension

TERMINATED NA

SupportBP 2.0:Behavioral Science and Enrollment in Remote Monitoring for Hypertension Management

NCT04714398

Hypertension

COMPLETED NA

A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study

NCT06228417

Hypertension

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single-arm: Blood pressure intervention

Participants will use a mobile technology system comprising of a remote home blood pressure monitoring cuff and a mobile application integrated with a clinician-facing component to view and manage remote blood pressures. Participants will use this for 12 weeks, with assessment of blood pressure outcomes and anonymous surveys regarding the technology at 12 weeks.

Group Type EXPERIMENTAL

Mobile technology intervention

Intervention Type COMBINATION_PRODUCT

Home blood pressure cuff used by patients twice a week, with blood pressures transmitted to providers remotely

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile technology intervention

Home blood pressure cuff used by patients twice a week, with blood pressures transmitted to providers remotely

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older with an established diagnosis of essential hypertension

Exclusion Criteria

* Patients on more than 2 antihypertensives at time of enrollment
* Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following:
* Renal artery stenosis
* Primary hyperaldosteronism
* Cushing syndrome
* Coarctation of the aorta
* Drug-induced hypertension
* Pheochromocytoma
* Obstructive sleep apnea
* Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months
* Hospitalization for unstable angina or myocardial infarction in the preceding 6 months
* Prior diagnosis of heart failure or cardiomyopathy
* Stroke or transient ischemic attack within prior 6 months
* Prior organ transplantation
* Failure to obtain informed consent
* Pregnant or currently trying to become pregnant
* Patients who are enrolled in other research studies

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes